Sponsor Name
National Institutes of Health
Program Title
Other Sponsor Resources
N/A
Deadline
Jul 20, 2020
Letter of Intent/Pre-Application
Optional
Letter Of Intent/Pre-Application Date
Jun 20, 2020
Submission
Unlimited
Eligibility
Senior
, Junior
, Non-Tenure
, Tenure
Sponsor Type
Federal
Award Type
Cooperative Agreement
F&A Level
Full
Fringe Benefit
Allowed
Managing Office
SR-PD
Purpose
To support studies of the mechanism of action of a combination of two or more vaccine adjuvants (combination adjuvant). The long-term goal is to promote the development of novel adjuvant combinations which will improve the immunogenicity of vaccines while limiting or eliminating reactogenicity.
Citizenship
Not Restricted
Amount
Limited to $400,000/year over a 5 year period
Success Rate
5 - 6 awards anticipated
Date Entered
Feb 6, 2020